By facilitating ‎the ‎infiltration of immune cells into the tumor microenvironment, CXCL10 not only impairs ‎tumor ‎growth and metastasis, but also disrupts angiogenesis, which is essential for the ‎blood supply and ‎spread of the tumor. Here, CXCL10 is linked to neoplasm.